Page 6 - Therapeutics Public News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapeutics public. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapeutics Public Today - Breaking & Trending Today

Horizon Therapeutics Public (NASDAQ:HZNP) Earns Buy Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a report published on Thursday. The brokerage issued a buy rating on the biopharmaceutical company’s stock. Separately, TheStreet cut Horizon Therapeutics Public from a b- rating to a c+ rating in a research note on Monday, May 8th. Seven research analysts […] ....

Stansberry Asset Management , Kiwi Wealth Investments Limited Partnership , Wahed Invest , Horizon Therapeutics Public Limited Company , Horizon Therapeutics Public , Free Report , Therapeutics Public , Get Free Report , Asset Management , Wealth Investments Limited Partnership , Therapeutics Public Limited Company , Horizon Therapeutics Public Daily , Nasdaq Hznp , Initiated Coverage , Stocknews Com ,

Pictet Asset Management SA Has $94.74 Million Stock Position in Horizon Therapeutics Public Limited (NASDAQ:HZNP)

Pictet Asset Management SA lessened its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 44.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 868,045 shares of the biopharmaceutical company’s stock after selling 707,473 shares during the […] ....

Securities Exchange Commission , Elequin Securities , Horizon Therapeutics Public , Financial Management Inc , Ameritas Advisory Services , Horizon Therapeutics Public Limited , Horizon Therapeutics Public Limited Company , Corecap Advisors , Samalin Investment Counsel , Pictet Asset Management , Free Report , Asset Management , Cap Advisors , Advisory Services , Therapeutics Public , Get Free Report , Therapeutics Public Limited Company , Visit Holdingschannel , Horizon Therapeutics Public Daily , Nasdaq Hznp , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Pictet Asset Management SA Reduces Stock Holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP)

Pictet Asset Management SA cut its stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 44.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 868,045 shares of the biopharmaceutical company’s stock after selling 707,473 shares during the […] ....

Kellner Capital , Crystalline Management Inc , Capstone Investment Advisors , Horizon Therapeutics Public Limited , Tower Research Capital , Horizon Therapeutics Public Limited Company , Horizon Therapeutics Public , Securities Exchange Commission , Pictet Asset Management , Free Report , Asset Management , Investment Advisors , Research Capital , Therapeutics Public Limited , Therapeutics Public , Get Free Report , Therapeutics Public Limited Company , Visit Holdingschannel , Horizon Therapeutics Public Daily , Nasdaq Hznp , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Horizon Therapeutics Public Limited (NASDAQ:HZNP) Expected to Earn Q4 2023 Earnings of $1.88 Per Share

Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) – Research analysts at HC Wainwright raised their Q4 2023 earnings per share (EPS) estimates for shares of Horizon Therapeutics Public in a note issued to investors on Wednesday, August 9th. HC Wainwright analyst D. Tsao now expects that the biopharmaceutical company will earn $1.88 per share […] ....

Horizon Therapeutics Public Limited Company , Wahed Invest , Horizon Therapeutics Public Limited , Kiwi Wealth Investments Limited Partnership , Gamco Investors , Free Report , Horizon Therapeutics Public , Therapeutics Public , Get Free Report , Wealth Investments Limited Partnership , Therapeutics Public Limited Company , Horizon Therapeutics Public Daily , Nasdaq Hznp , Earnings Estimates , Hc Wainwright ,

Horizon Therapeutics Public Limited (NASDAQ:HZNP) Receives $110.71 Average Target Price from Analysts

Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Free Report) has received a consensus rating of “Hold” from the seven analysts that are presently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold rating. The average twelve-month target price among brokerages that have issued a report on the stock […] ....

United Kingdom , Horizon Therapeutics Public Limited , Baird Financial Group Inc , Renaissance Technologies , Horizon Therapeutics Public Company Profile , Horizon Therapeutics Public Limited Company , Get Free Report , Horizon Therapeutics Public , Therapeutics Public , Two Investors , Teachers Pension Plan Board , Baird Financial Group , Financial Group , Get Free , Therapeutics Public Limited Company , Horizon Therapeutics Public Daily , Nasdaq Hznp ,